Northwestern Mutual Wealth Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
Other funds holding SEEL
WE
AI
GJL
MWM
Northwestern Mutual Wealth Management's SEEL Position: Q4 2023 in Review
Northwestern Mutual Wealth Management held its Seelos Therapeutics, Inc. Common Stock (SEEL) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3712.
Northwestern Mutual Wealth Management first reported a position in SEEL in Q2 2023 and has held it in 1 quarter since. The position peaked at $2.99K in Q2 2023. 32 funds tracked by Wall St. Rank hold SEEL as of Q4 2023.
- Northwestern Mutual Wealth Management held 0 shares of Seelos Therapeutics, Inc. Common Stock worth $0 as of Q4 2023.
- Northwestern Mutual Wealth Management left its Seelos Therapeutics, Inc. Common Stock share count unchanged in Q4 2023.
- Seelos Therapeutics, Inc. Common Stock made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q4 2023, its #3712 holding.
- Northwestern Mutual Wealth Management first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2023 and has held it in 1 quarter since.
- Northwestern Mutual Wealth Management's Seelos Therapeutics, Inc. Common Stock position peaked at $2.99K in Q2 2023.
- 32 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2023.
Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2023, filed 13 Feb 2024.